Stock data
Werewolf Therapeutics, Inc. (HOWL)
Werewolf Therapeutics, Inc. (HOWL) reported net income of -US$60.82M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$60.68M | -US$60.82M | — |
| 2024 | — | — | -US$73.59M | -US$70.52M | — |
| 2023 | — | — | -US$40.50M | -US$37.37M | — |
| 2022 | — | — | -US$56.06M | -US$53.81M | — |
| 2021 | — | — | -US$50.09M | -US$49.98M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$3.67M | — |
| 2026-03-31 | — | -US$13.53M | — |
| 2025-12-31 | — | -US$8.38M | — |
| 2025-09-30 | — | -US$16.37M | — |
| 2025-06-30 | — | -US$17.98M | — |
| 2025-03-31 | — | -US$18.09M | — |
| 2024-12-31 | — | -US$20.40M | — |
| 2024-09-30 | — | -US$16.67M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.